Post-approval studies (Phase 4)Study completedNCT07431476
What this trial is testing
Brimonidine 0.33% for Rosacea-Related Facial Erythema
Who this might be right for
RosaceaRosacea Subtype 1 (Erythematotelangiectatic)
Istanbul Training and Research Hospital 45